SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MythMan who wrote (19316)3/8/1999 1:14:00 PM
From: Mark A. Stang  Read Replies (2) of 23519
 
More than a short squeeze--

The news, patent on female sexual dysfunction treatment, isn't even on Yahoo yet.

This will be more that a one day move on news of a milestone payment. (Amazing that even briefing.com hasn't gotten the news yet.) This means that VVUS has long-term growth prospects beyond the gains from a domestic U.S. partner for MUSE. Once we hit 5, the funds can and will buy back in.

If I were a long-term shorter of VVUS, I would cover NOW and not even think about shorting again until 10+. Who knows if Leland's planning to drop another shoe or two.

Today's sellers, even day-traders, are foolishly selling cheap.

VLAD, where the hell are you?

I've got to get off the rest of the day for a deposition. See you tonight.

Long at 25,000 shares. My buddy is long at 40,000 shares. We're not selling one share at these low prices.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext